The global market for Next Generation Antibody Therapeutics was valued at US$ 12260 million in the year 2024 and is projected to reach a revised size of US$ 43680 million by 2031, growing at a CAGR of 20.0% during the forecast period.

Next Generation Antibody Therapeutics Market

Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.

The global next-generation antibody therapeutics market is expected to grow significantly over the next decade, driven by the increasing prevalence of cancer, autoimmune diseases, and infectious diseases, along with advancements in biotechnology. Oncology will remain the largest segment, but there will be strong growth in autoimmune diseases, infectious diseases, and neurological conditions.

In conclusion, technological advancements, regulatory support, and the increasing use of antibodies in combination therapies will continue to fuel the market's growth, making next-gen antibody therapeutics one of the most promising areas in biopharmaceutical innovation.Global key players of next generation antibody therapeutics include Roche, Seagen, Amgen, Pfizer, Takeda, etc. The top two players hold a share over 70%. North America is the largest market, has a share about 65%, followed by Europe and Asia-Pacific, with share 16% and 15%, separately. In terms of product type, Antibody Drug Conjugate (ADC) is the largest segment, occupied for a share of 60%, and in terms of application, Cancer has a share about 66 %.

This report aims to provide a comprehensive presentation of the global market for Next Generation Antibody Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Antibody Therapeutics.

The Next Generation Antibody Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Next Generation Antibody Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Next Generation Antibody Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Next Generation Antibody Therapeutics Market Report

Report Metric	Details
Report Name	Next Generation Antibody Therapeutics Market
Accounted market size in year	US$ 12260 million
Forecasted market size in 2031	US$ 43680 million
CAGR	20.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antibody Drug Conjugate (ADC) Bispecific Antibody (BsAb)
Segment by Application	Cancer Haemophilia Other Non-Cancer Diseases
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Amgen, Pfizer, Takeda, Daiichi Sankyo, Seagen, Astellas, Immunomedics, GSK, Immunocore, ADC Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Antibody Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Next Generation Antibody Therapeutics Market growing?

Ans: The Next Generation Antibody Therapeutics Market witnessing a CAGR of 20.0% during the forecast period 2025-2031.

What is the Next Generation Antibody Therapeutics Market size in 2031?

Ans: The Next Generation Antibody Therapeutics Market size in 2031 will be US$ 43680 million.

What is the market share of major companies in Next Generation Antibody Therapeutics Market?

Ans: The top two players hold a share over 70%.

What is the Next Generation Antibody Therapeutics Market share by region?

Ans: North America is the largest market, has a share about 65%, followed by Europe and Asia-Pacific, with share 16% and 15%, separately.

What is the Next Generation Antibody Therapeutics Market share by type?

Ans: In terms of product type, Antibody Drug Conjugate (ADC) is the largest segment, occupied for a share of 60%, and in terms of application, Cancer has a share about 66 %.

Who are the main players in the Next Generation Antibody Therapeutics Market report?

Ans: The main players in the Next Generation Antibody Therapeutics Market are Roche, Amgen, Pfizer, Takeda, Daiichi Sankyo, Seagen, Astellas, Immunomedics, GSK, Immunocore, ADC Therapeutics

What are the Application segmentation covered in the Next Generation Antibody Therapeutics Market report?

Ans: The Applications covered in the Next Generation Antibody Therapeutics Market report are Cancer, Haemophilia, Other Non-Cancer Diseases

What are the Type segmentation covered in the Next Generation Antibody Therapeutics Market report?

Ans: The Types covered in the Next Generation Antibody Therapeutics Market report are Antibody Drug Conjugate (ADC), Bispecific Antibody (BsAb)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antibody Drug Conjugate (ADC)

1.2.3 Bispecific Antibody (BsAb)

1.3 Market by Application

1.3.1 Global Next Generation Antibody Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Haemophilia

1.3.4 Other Non-Cancer Diseases

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Next Generation Antibody Therapeutics Market Perspective (2020-2031)

2.2 Global Next Generation Antibody Therapeutics Growth Trends by Region

2.2.1 Global Next Generation Antibody Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Next Generation Antibody Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Next Generation Antibody Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Next Generation Antibody Therapeutics Market Dynamics

2.3.1 Next Generation Antibody Therapeutics Industry Trends

2.3.2 Next Generation Antibody Therapeutics Market Drivers

2.3.3 Next Generation Antibody Therapeutics Market Challenges

2.3.4 Next Generation Antibody Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Next Generation Antibody Therapeutics Players by Revenue

3.1.1 Global Top Next Generation Antibody Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Next Generation Antibody Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Next Generation Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Next Generation Antibody Therapeutics Revenue

3.4 Global Next Generation Antibody Therapeutics Market Concentration Ratio

3.4.1 Global Next Generation Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next Generation Antibody Therapeutics Revenue in 2024

3.5 Global Key Players of Next Generation Antibody Therapeutics Head office and Area Served

3.6 Global Key Players of Next Generation Antibody Therapeutics, Product and Application

3.7 Global Key Players of Next Generation Antibody Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Next Generation Antibody Therapeutics Breakdown Data by Type

4.1 Global Next Generation Antibody Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2026-2031)

5 Next Generation Antibody Therapeutics Breakdown Data by Application

5.1 Global Next Generation Antibody Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Next Generation Antibody Therapeutics Market Size (2020-2031)

6.2 North America Next Generation Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Next Generation Antibody Therapeutics Market Size by Country (2020-2025)

6.4 North America Next Generation Antibody Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Next Generation Antibody Therapeutics Market Size (2020-2031)

7.2 Europe Next Generation Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Next Generation Antibody Therapeutics Market Size by Country (2020-2025)

7.4 Europe Next Generation Antibody Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Next Generation Antibody Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Next Generation Antibody Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Next Generation Antibody Therapeutics Market Size (2020-2031)

9.2 Latin America Next Generation Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Next Generation Antibody Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Next Generation Antibody Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Next Generation Antibody Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Next Generation Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Next Generation Antibody Therapeutics Introduction

11.1.4 Roche Revenue in Next Generation Antibody Therapeutics Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Next Generation Antibody Therapeutics Introduction

11.2.4 Amgen Revenue in Next Generation Antibody Therapeutics Business (2020-2025)

11.2.5 Amgen Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Next Generation Antibody Therapeutics Introduction

11.3.4 Pfizer Revenue in Next Generation Antibody Therapeutics Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Next Generation Antibody Therapeutics Introduction

11.4.4 Takeda Revenue in Next Generation Antibody Therapeutics Business (2020-2025)

11.4.5 Takeda Recent Development

11.5 Daiichi Sankyo

11.5.1 Daiichi Sankyo Company Details

11.5.2 Daiichi Sankyo Business Overview

11.5.3 Daiichi Sankyo Next Generation Antibody Therapeutics Introduction

11.5.4 Daiichi Sankyo Revenue in Next Generation Antibody Therapeutics Business (2020-2025)

11.5.5 Daiichi Sankyo Recent Development

11.6 Seagen

11.6.1 Seagen Company Details

11.6.2 Seagen Business Overview

11.6.3 Seagen Next Generation Antibody Therapeutics Introduction

11.6.4 Seagen Revenue in Next Generation Antibody Therapeutics Business (2020-2025)

11.6.5 Seagen Recent Development

11.7 Astellas

11.7.1 Astellas Company Details

11.7.2 Astellas Business Overview

11.7.3 Astellas Next Generation Antibody Therapeutics Introduction

11.7.4 Astellas Revenue in Next Generation Antibody Therapeutics Business (2020-2025)

11.7.5 Astellas Recent Development

11.8 Immunomedics

11.8.1 Immunomedics Company Details

11.8.2 Immunomedics Business Overview

11.8.3 Immunomedics Next Generation Antibody Therapeutics Introduction

11.8.4 Immunomedics Revenue in Next Generation Antibody Therapeutics Business (2020-2025)

11.8.5 Immunomedics Recent Development

11.9 GSK

11.9.1 GSK Company Details

11.9.2 GSK Business Overview

11.9.3 GSK Next Generation Antibody Therapeutics Introduction

11.9.4 GSK Revenue in Next Generation Antibody Therapeutics Business (2020-2025)

11.9.5 GSK Recent Development

11.10 Immunocore

11.10.1 Immunocore Company Details

11.10.2 Immunocore Business Overview

11.10.3 Immunocore Next Generation Antibody Therapeutics Introduction

11.10.4 Immunocore Revenue in Next Generation Antibody Therapeutics Business (2020-2025)

11.10.5 Immunocore Recent Development

11.11 ADC Therapeutics

11.11.1 ADC Therapeutics Company Details

11.11.2 ADC Therapeutics Business Overview

11.11.3 ADC Therapeutics Next Generation Antibody Therapeutics Introduction

11.11.4 ADC Therapeutics Revenue in Next Generation Antibody Therapeutics Business (2020-2025)

11.11.5 ADC Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antibody Drug Conjugate (ADC)

Table 3. Key Players of Bispecific Antibody (BsAb)

Table 4. Global Next Generation Antibody Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Next Generation Antibody Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Next Generation Antibody Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Next Generation Antibody Therapeutics Market Share by Region (2020-2025)

Table 8. Global Next Generation Antibody Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Next Generation Antibody Therapeutics Market Share by Region (2026-2031)

Table 10. Next Generation Antibody Therapeutics Market Trends

Table 11. Next Generation Antibody Therapeutics Market Drivers

Table 12. Next Generation Antibody Therapeutics Market Challenges

Table 13. Next Generation Antibody Therapeutics Market Restraints

Table 14. Global Next Generation Antibody Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Next Generation Antibody Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Antibody Therapeutics as of 2024)

Table 17. Ranking of Global Top Next Generation Antibody Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Next Generation Antibody Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Next Generation Antibody Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Next Generation Antibody Therapeutics, Product and Application

Table 21. Global Key Players of Next Generation Antibody Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Next Generation Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Next Generation Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Next Generation Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Next Generation Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Next Generation Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Next Generation Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Next Generation Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Next Generation Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Next Generation Antibody Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Next Generation Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Next Generation Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Next Generation Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Next Generation Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Roche Company Details

Table 47. Roche Business Overview

Table 48. Roche Next Generation Antibody Therapeutics Product

Table 49. Roche Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 50. Roche Recent Development

Table 51. Amgen Company Details

Table 52. Amgen Business Overview

Table 53. Amgen Next Generation Antibody Therapeutics Product

Table 54. Amgen Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Amgen Recent Development

Table 56. Pfizer Company Details

Table 57. Pfizer Business Overview

Table 58. Pfizer Next Generation Antibody Therapeutics Product

Table 59. Pfizer Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Pfizer Recent Development

Table 61. Takeda Company Details

Table 62. Takeda Business Overview

Table 63. Takeda Next Generation Antibody Therapeutics Product

Table 64. Takeda Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Takeda Recent Development

Table 66. Daiichi Sankyo Company Details

Table 67. Daiichi Sankyo Business Overview

Table 68. Daiichi Sankyo Next Generation Antibody Therapeutics Product

Table 69. Daiichi Sankyo Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 70. Daiichi Sankyo Recent Development

Table 71. Seagen Company Details

Table 72. Seagen Business Overview

Table 73. Seagen Next Generation Antibody Therapeutics Product

Table 74. Seagen Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Seagen Recent Development

Table 76. Astellas Company Details

Table 77. Astellas Business Overview

Table 78. Astellas Next Generation Antibody Therapeutics Product

Table 79. Astellas Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Astellas Recent Development

Table 81. Immunomedics Company Details

Table 82. Immunomedics Business Overview

Table 83. Immunomedics Next Generation Antibody Therapeutics Product

Table 84. Immunomedics Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 85. Immunomedics Recent Development

Table 86. GSK Company Details

Table 87. GSK Business Overview

Table 88. GSK Next Generation Antibody Therapeutics Product

Table 89. GSK Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 90. GSK Recent Development

Table 91. Immunocore Company Details

Table 92. Immunocore Business Overview

Table 93. Immunocore Next Generation Antibody Therapeutics Product

Table 94. Immunocore Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 95. Immunocore Recent Development

Table 96. ADC Therapeutics Company Details

Table 97. ADC Therapeutics Business Overview

Table 98. ADC Therapeutics Next Generation Antibody Therapeutics Product

Table 99. ADC Therapeutics Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 100. ADC Therapeutics Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Next Generation Antibody Therapeutics Picture

Figure 2. Global Next Generation Antibody Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Next Generation Antibody Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Antibody Drug Conjugate (ADC) Features

Figure 5. Bispecific Antibody (BsAb) Features

Figure 6. Global Next Generation Antibody Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Next Generation Antibody Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. Cancer Case Studies

Figure 9. Haemophilia Case Studies

Figure 10. Other Non-Cancer Diseases Case Studies

Figure 11. Next Generation Antibody Therapeutics Report Years Considered

Figure 12. Global Next Generation Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Next Generation Antibody Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Next Generation Antibody Therapeutics Market Share by Region: 2024 VS 2031

Figure 15. Global Next Generation Antibody Therapeutics Market Share by Players in 2024

Figure 16. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Antibody Therapeutics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Next Generation Antibody Therapeutics Revenue in 2024

Figure 18. North America Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Next Generation Antibody Therapeutics Market Share by Country (2020-2031)

Figure 20. United States Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Next Generation Antibody Therapeutics Market Share by Country (2020-2031)

Figure 24. Germany Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Next Generation Antibody Therapeutics Market Share by Region (2020-2031)

Figure 32. China Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Next Generation Antibody Therapeutics Market Share by Country (2020-2031)

Figure 40. Mexico Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Next Generation Antibody Therapeutics Market Share by Country (2020-2031)

Figure 44. Turkey Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Roche Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)

Figure 48. Amgen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)

Figure 49. Pfizer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)

Figure 50. Takeda Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)

Figure 51. Daiichi Sankyo Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)

Figure 52. Seagen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)

Figure 53. Astellas Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)

Figure 54. Immunomedics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)

Figure 55. GSK Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)

Figure 56. Immunocore Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)

Figure 57. ADC Therapeutics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Fenoxaprop-p-ethyl Formulation Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17P19155

Mon Feb 17 00:00:00 UTC 2025

Add to Cart

Global General Medicines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6U19155

Mon Feb 17 00:00:00 UTC 2025

Add to Cart

Global Plasma Medicine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5K10490

Mon Feb 17 00:00:00 UTC 2025

Add to Cart

Global No Additive Collection Tubes Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4V10808

Mon Feb 17 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions